Issue Price
₹ 58-₹ 61
per equity share
Issue Size
34.44 lakhs
equity share
Face Value
₹ 10
per equity share
Market Lot
2000
equity share
Please note
Listing at NSE
ONYX BIOTEC LIMITED
Important Dates
IPO Open Date
13 Nov 2024
IPO Close Date
18 Nov 2024
Allotment Date
19 Nov 2024
Initiation of Refunds
20 Nov 2024
Credit of Shares to Demat Account
20 Nov 2024
IPO Listing Date
21 Nov 2024
UPI Mandate Expiry Date
18 Nov 2024
IPO Details
Onyx Biotec IPO issue size is 48.10 lakh equity shares. This IPO is offering entirely a fresh issue. The price band is decided at Rs 58 to Rs 61 per share. Onyx Biotec IPO 1 lot consists of 2000 shares. The minimum investment for the retail category is to be around Rs 122,000. The allotment status will be released on Tuesday, November 19, 2024. The listing will be on the NSE SME platform on Thursday, November 21, 2024. Onyx Biotec IPO registrar is Mas Services Limited. On the date of allotment, Investors can visit on Mas Services Limited website and, select the name of the company and enter PAN number or application ID to know their allotment status.
Seize the deal, apply for IPO today!
Apply for IPOAbout ONYX BIOTEC LIMITED
Onyx Biotec Limited, established in 2005, is a prominent pharmaceutical company based in Himachal Pradesh, India. Specializing in the production of parenteral products, it offers a range of sterile solutions, including polyethene ampoules. Onyx Biotec has received recognition for its commitment to quality and innovation in drug manufacturing. Its focus on meeting healthcare needs places the company in an important position to supply essential medications across the region. With its strategic location near Solan, its distribution capabilities are well enhanced to provide efficient service delivery. As an exact brand name that encourages trust in the pharmacy market, Onyx Biotec continues to further the development of products while upholding regulatory rigour at its best, thus contributing substantially towards the health sector of India.
Parent Organisation
-
Founded
2005
Managing Director
Kantilal Jethva and Bhavin Jethwa
IPO Objectives
The company plans to use the Net Proceeds from the issue to upgrade its existing manufacturing Unit I to produce large-volume parentals for intravenous use, establish a high-speed carton packaging line at manufacturing Unit II for dry powder injections, repay or prepay a portion of its loans, and for general corporate purposes.
How to apply for IPO
- Login to your Bigul account and select the issue in the current IPO section
- Enter the number of lots and price at which you wish to apply for
- Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange
- You will receive a mandate notification to block funds in your UPI app
- Approve the mandate request on your UPI and funds will be blocked
Open Demat Account in 5 Minutes
Keep these documents ready
PAN Card | Aadhaar Card | Bank Account Number
Close